Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 34Terminated 7Unknown 4Withdrawn 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Anemia, Refractory, with Excess of Blasts 2Recurrence 1Non-Malignant Neoplasm 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

asciminib 4ponatinib 2nilotinib 2Dasatinib 2pegylated granulocyte colony-stimulating factor 1olverembatinib 1letermovir 1fludarabine phosphate 1decitabine and cedazuridine drug combination 1bosutinib 1Whole-Body Irradiation 1Stem Cell Transplantation 1Specimen Handling 1Rituximab 1Practice Management, Medical 1Positron-Emission Tomography 1Melphalan 1Interviews as Topic 1Imatinib Mesylate 1Drug Monitoring 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1Busulfan 1Bone Marrow Purging 1Blood Component Removal 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myeloid, Chronic-Phase × Antilymphocyte Serum × Clear all
NCT02727803 2026-05-22

Personalized NK Cell Therapy in CBT

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡